Decoding β-catenin associated protein-protein interactions: Emerging cancer therapeutic opportunities

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The Wnt/β-catenin signaling pathway is crucial in cancer progression.
• β-catenin is a central regulator of tumor-promoting activities.
• Aberrant β-catenin signaling is implicated in various malignancies.

Purpose of the Study:

• To review the role of β-catenin's protein-protein interactions (PPIs) in cancer.
• To highlight the challenges and potential of targeting β-catenin PPIs for cancer therapy.
• To discuss emerging technologies and future directions in β-catenin-targeted drug development.

Main Methods:

• Literature review focusing on β-catenin signaling and its associated protein-protein interactions (PPIs).
• Analysis of preclinical evidence supporting β-catenin as a therapeutic target.
• Exploration of challenges in developing β-catenin inhibitors.
• Discussion of the role of PPIs in oncogenesis and the tumor microenvironment.

Main Results:

• β-catenin's PPI network is vital for multiple stages of cancer, including metastasis and immune evasion.
• Targeting these PPIs presents a promising strategy for novel cancer therapies.
• Despite being considered 'undruggable,' advancements in understanding β-catenin's interactions offer new hope.

Conclusions:

• Understanding β-catenin's PPI network is key to deciphering oncogenic mechanisms.
• Targeting β-catenin PPIs holds significant therapeutic potential for various cancers.
• Overcoming current challenges requires innovative technologies and further research into β-catenin biology.